Rising Prevalence Of Blood Disorders Drives Growth In The Coagulation Markers Market: Transformative Forces Shaping the Coagulation Markers Market Landscape in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Coagulation Markers Industry Market Size Be by 2025?
The market size for coagulation markers has noticeably expanded in the past few years. Projected growth shows an increase from $1.16 billion in 2024 to $1.25 billion in 2025, giving a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this upward trend in the historic period include the escalating incidence of cardiovascular diseases, an aging demographic, a rise in surgical procedures, enhanced awareness and early diagnosis measures, government support and funding, along with growth in the healthcare infrastructure.

What's the Long-Term Growth Forecast for the Coagulation Markers Market Size Through 2029?
Anticipated to observe significant expansion in upcoming years, the coagulation markers market is projected to escalate to $1.63 billion by 2029, with a 6.9% CAGR. This predicted growth within the forecast period can be linked back to the multiplying number of chronic disease cases, increased acceptance of customized medicine, a swelling global human population, escalating healthcare costs, and sprouting markets in emergent economies. Crucial evolving trends within the forecast duration encompass the incorporation of artificial intelligence and machine learning, the emergence of innovative biomarkers, improved point-of-care technologies, the automation trend in labs, the adoption of wearable healthcare technology, telehealth and distant patient tracking, and adoption of sustainable diagnostic methodologies.

View the full report here:
https://www.thebusinessresearchcompany.com/report/coagulation-markers-global-market-report

What Are the Key Growth Drivers Fueling the Coagulation Markers Market Expansion?
The increasing number of blood disorder cases is predicted to spur the growth of the coagulation markers market. Blood disorders, which encompass a variety of conditions that hinder the proper functioning of blood, are on the rise due to aging populations, heightened awareness, and enhanced diagnostic capabilities. By evaluating clotting function, highlighting abnormalities, and tracking treatment effectiveness for conditions like hemophilia and thrombosis, coagulation markers play an essential role in diagnosing and managing blood disorders. For example, the Leukaemia Foundation, an Australia-based non-profit organization, revealed that as of May 2024, approximately 135,000 individuals in Australia have a blood cancer or blood disorder. They predict that this figure will surge beyond 275,000 by 2035. Consequently, the escalating prevalence of blood disorders is boosting the coagulation marker market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17117&type=smp

What Are the Key Trends Driving Coagulation Markers Market Growth?
Leading enterprises in the coagulation markers market are prioritizing the creation of technologically advanced solutions, such as D-dimer kits, to enhance the pace and precision of blood clot-related diagnoses. The D-dimer kits are diagnostic instruments that estimate the quantity of D-dimer, a protein fragment that is generated when a blood clot is dissolved. This aids in the detection and evaluation of clot-related disorders such as deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a biotechnology firm based in the US, introduced the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic instrument is intended for veterinary use and offers five tests per kit to monitor D-dimer levels, a coagulation indicator. It assists in detecting conditions like thrombosis, sepsis, and DIC in veterinary practices.

How Is the Coagulation Markers Market Segmented?
The coagulation markers market covered in this report is segmented -

1) By Product: D-Dimer Assay, Fibrinogen Assay
2) By Sample Type: Plasma, Whole Blood Sample, Other Sample Types
3) By Technology: Fluorescence Immunoassay, Enzyme-Linked Immuno Sorbent Assay (ELISA), Rapid Test, Particle Enhanced Immunoturbidimetric Assay
4) By Application: Deep Venous Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Trauma, Other Applications
5) By End User: Hospital, Specialty Clinics, Academic And Research Institute, Diagnostics Laboratories

Subsegments:
1) By D-Dimer Assay: ELISA-Based D-Dimer Assay, Lateral Flow Immunoassay D-Dimer Test, Chemiluminescent Immunoassay D-Dimer Test
2) By Fibrinogen Assay: Clauss Fibrinogen Assay, Functional Fibrinogen Assay, Automated Fibrinogen Assay

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=17117&type=smp

Which Companies Are Leading the Charge in Coagulation Markers Market Innovation?
Major companies operating in the coagulation markers market are Siemens Healthineers, Roche Holding AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Quidel Corporation, Sysmex Corporation, Bio-Rad Laboratories Inc., Werfen Group, Nihon Kohden Corporation, Randox Laboratories Ltd, Stago Group, Sekisui Diagnostics, Helena Laboratories Italia Spa, Tulip Diagnostics Ltd, Trinity Biotech PLC, CTK Biotech Inc., International Technidyne Corporation (ITC), Diazyme Laboratories Inc., AdvaCare Pharma USA (AccuQuik Test Kits), Technoclone GmbH, BioMedica Diagnostics Inc., Eurolyser Diagnostica GmbH, Goldsite Diagnostics Inc., Hipro Biotechnology Co. Ltd., HYPHEN BioMed

Which Regions Are Leading the Global Coagulation Markers Market in Revenue?
North America was the largest region in the coagulation markers market in 2024. The regions covered in the coagulation markers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17117

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.